GenAI models demonstrate high accuracy and consistency in pathological grading and risk assessment for lung adenocarcinoma.
Key Details
- 1Study tested GPT-4o, Claude-3.5-Sonnet, and Gemini-1.5-Pro on 492 digitized slides from public and independent sources.
- 2Claude-3.5-Sonnet achieved 82.3% accuracy in lung adenocarcinoma grading, with strong repeatability.
- 3Models extracted 11 histological features and 4 clinical variables for comprehensive risk assessment.
- 4Diagnostic and prognostic tasks were completed in minutes, much faster than human experts.
- 5AI models reduced inter-observer variability and enabled objective, standardized analysis across multiple samples.
- 6GenAI models surfaced new significant prognostic factors including interstitial fibrosis and papillary patterns.
Why It Matters
This breakthrough underscores the transformative potential of generative AI in digital pathology, promising faster, standardized, and potentially more insightful cancer diagnosis and prognosis translation. Such advances could boost accuracy in resource-limited settings and improve reproducibility in pathological assessments, reshaping clinical workflows.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.